News & Articles

Two-year follow up of the CodeBreaK100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile

Patients with recurrent lesions genetically distinct from the primary tumor may require different treatment

AACR President David A. Tuveson will chair the symposium titled: Aging, Stress, and Cancer.

AACR President David A. Tuveson says clinicians will be ready and waiting before the cancer appears in the future

Researchers have found that a third COVID-19 vaccine increases vaccine effectiveness

New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics

Companies will showcase combined solution at American Association for Cancer Research (AACR) Annual Meeting 2022

Scientific Solutions business splits from global medtech company

Rice process customizes one-, two- or three-element doping for applications

The new technology hopes to help patients in remote areas across the world, through deep learning

Increased levels of blood fats in people with type 2 diabetes and obesity are more harmful than previously thought, a new study has found

A substantial increase in deaths in care homes in the first three months of the pandemic is likely to have contributed to the figure

Software which helps speed up the process of creating new diagnostic tests could help combat future pandemics, its developers say.

The service aims to support the discovery and early pre-clinical development of RNA-based therapeutics and vaccines.

Unhealthy lifestyles are associated with a higher risk of severe COVID-19, but risks are highest in the most economically disadvantaged, according to a new study

The Dianthus instrument includes breakthrough Spectral Shift technology for affinity-based screenings in drug discovery

Pipetting robot has helped an Arbovirus testing lab streamline its sample pooling and reduce the use of plastic labware

Scientists have identified a protein, GIT1, as a modulator of Notch signaling and a guardian against breast cancer growth